Definitive Contract 36C25722C0048
- Not listed
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sirtex Medical Inc., a global healthcare company that provides medical devices and therapies for cancer treatment. The contract is for the purchase of Y-90 SIR-Spheres, which are resin microspheres used in selective internal radiation therapy to treat inoperable liver tumors and metastatic disease in veterans and military members. The potential value of the contract is $142,000.00, and it has a...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a for-profit organization based in Woburn, Massachusetts. The $37,688.00 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a specialized radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The contract has an ultimate completion date of September 30, 2024. Sirtex Medical Inc. has a history of providing these advanced cancer...
- This is a firm fixed-price federal contract award from the Medical Command (MEDCOM) agency of the Department of Defense to Sirtex Medical Inc., a for-profit medical device manufacturer headquartered in Woburn, Massachusetts. The $144,000.00 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat inoperable liver tumors and metastatic colorectal cancer. The contract does not have a set-aside designation. Sirtex Medical has a history...
- This is a firm fixed-price BPA (Blanket Purchase Agreement) call awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Sirtex Medical Inc., a for-profit medical device manufacturer headquartered in Woburn, Massachusetts. The contract is for the supply of SIR-Sphere Y-90 resin microspheres, a targeted radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The ceiling value of the contract is...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a firm fixed-price purchase order to Sirtex Medical Inc. on April 3, 2025, for Y-90 SIR-Spheres resin microspheres, specialized medical devices used in selective internal radiation therapy (SIRT) procedures for treating liver cancer and metastatic colorectal cancer in veterans. The contract carries a ceiling value of $241,030 with an ultimate completion date of April 1, 2028. The award was made through full and...
- This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a medical device manufacturer specializing in cancer therapies. The $320,000.00 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The contract has no set-aside designation and supports the provision of specialized medical devices and related materials to the Department of...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Sirtex Medical Inc., a for-profit medical device manufacturer based in Woburn, Massachusetts. The contract, valued at $480,000.00, is a Blanket Purchase Agreement (BPA) call for the supply of SIR-Sphere microspheres, a targeted radiation therapy used to treat liver tumors and metastatic colorectal cancer. The contract supports the VA Palo Alto Health Care System (VAPAHCS) and does not have a set-aside...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Sirtex Medical Inc., a global healthcare company specializing in cancer therapies. The $19,295 contract is for the delivery of Y-90 SIR-SPHERES resin microspheres, a targeted radiation therapy product used to treat liver tumors and metastatic colorectal cancer. The contract supports cancer treatment for veterans and military personnel across the VA healthcare system. The award has a performance period...
- This firm fixed-price purchase order was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense (DOD) to Sirtex Medical Inc., a global healthcare company, to provide SIR-Spheres Y-90 resin microspheres. These radioactive microspheres are used in selective internal radiation therapy (SIRT) to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. The contract has a ceiling value of...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Sirtex Medical Inc., a for-profit medical technology company based in Woburn, Massachusetts. The contract is for the supply of SIR-Y002 Y-90 resin microspheres and SIR-K002 accessories, which are specialized radiation therapy products used to treat liver tumors and metastatic colorectal cancer. The contract has a ceiling value of $19,844.00 and an ultimate completion date of July 4, 2025....
This is a $17,750 firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Sirtex Medical Inc., a for-profit medical device manufacturer. The contract is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The award has a performance period through February 22, 2023, and is not designated as a set-aside contract. Sirtex Medical Inc. is a global healthcare company specializing in innovative cancer therapies, headquartered in Woburn, Massachusetts. The company has a robust history of federal contract awards with the VA and Defense Health Agency (DHA) for the provision of SIR-Spheres and related medical devices to support cancer treatment for veterans and military members.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($35k) | 1/16/25 | |
| P00002 | Supplemental Agreement for work within scope | ($18k) | 9/11/23 | |
| P00001 | Other Administrative Action | $0 | 3/31/22 | |
| Not listed | Not listed | $71.0k | 3/11/22 |